Yugen Chen
Impact in
-
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Pharmacology top 10%
- Pharmacological Effects of Natural Compounds
Papers in
-
- Gut microbiota and health 3
- RNA modifications and cancer 3
-
- Cancer-related molecular mechanisms research 3
- Cancer, Hypoxia, and Metabolism 3
- NF-κB Signaling Pathways 2
- Co-authors
- Jinjun Shan (2 shared papers)Bo Zhu (2 shared papers)Qinan Wu (2 shared papers)Liyun Shi (2 shared papers)Wei Zhang (2 shared papers)Cheng Cheng (2 shared papers)Jin‐Yong Zhou (4 shared papers)Haibo Cheng (2 shared papers)
- Journals
- Cellular & Molecular Biology Letters (2 papers)Scientific Reports (2 papers)The FASEB Journal (1 paper)PeerJ (1 paper)International Immunopharmacology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Yugen Chen
22 papers receiving 613 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 98
- Pharmacology 57
- Complementary and alternative medicine 34
- Molecular Biology 296
- Gastroenterology 17
Countries citing papers authored by Yugen Chen
This map shows the geographic impact of Yugen Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yugen Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yugen Chen more than expected).
Fields of papers citing papers by Yugen Chen
This network shows the impact of papers produced by Yugen Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yugen Chen. The network helps show where Yugen Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Yugen Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 86 | |
| 2 | 2019 | 83 | |
| 3 | 2023 | 83 | |
| 4 | 2019 | 68 | |
| 5 | 2019 | 55 | |
| 6 | 2021 | 47 | |
| 7 | 2019 | 36 | |
| 8 | 2021 | 35 | |
| 9 | 2021 | 21 | |
| 10 | 2015 | 21 | |
| 11 | 2022 | 16 | |
| 12 | 2015 | 16 | |
| 13 | 2021 | 11 | |
| 14 | 2023 | 10 | |
| 15 | 2012 | 7 | |
| 16 | 2021 | 6 | |
| 17 | 2024 | 5 | |
| 18 | Molecular screening and clinicopathologic characteristics of Lynch-like syndrome in a Chinese colorectal cancer cohort. | 2020 | 4 |
| 19 | 2023 | 3 | |
| 20 | [Effects of Baicalin on an orthotopic transplantation mouse model of mismatch repair gene deficient colorectal cancer]. | 2012 | 3 |
About Yugen Chen
Yugen Chen is a scholar working on Molecular Biology, Cancer Research, Immunology, Genetics and Oncology, having authored 26 papers that have together received 621 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (6 papers), Gut microbiota and health (3 papers), Immune cells in cancer (3 papers), RNA modifications and cancer (3 papers), Cancer-related molecular mechanisms research (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Galectins and Cancer Biology (2 papers) and NF-κB Signaling Pathways (2 papers). The work is most often cited by research in Cancer Research (98 citations), Pharmacology (57 citations), Complementary and alternative medicine (34 citations), Molecular Biology (296 citations) and Gastroenterology (17 citations). Yugen Chen has collaborated with scholars based in China and United States. Frequent co-authors include Jinjun Shan, Bo Zhu, Qinan Wu, Liyun Shi, Wei Zhang, Cheng Cheng, Jin‐Yong Zhou, Haibo Cheng, Qin Han and Jianming Guo. Their work appears in journals such as Cellular & Molecular Biology Letters, Scientific Reports, The FASEB Journal, PeerJ and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.